Oncology & Cancer

Inadequacies in current early-stage lung cancer treatment revealed

Researchers from Tohoku University and Tohoku University Hospital have revealed why some existing cancer treatments are ineffective in tackling the early-stages of lung cancer. A team led by Professor Tetsuya Kodama investigated ...

Oncology & Cancer

Common TB vaccine associated with lower lung cancer rates

(HealthDay)—Childhood vaccination with the bacille Calmette-Guérin (BCG) vaccine is associated with a reduced risk for lung cancer, according to a study published online Sept. 25 in JAMA Network Open.

Oncology & Cancer

Treatment beneficial for nonagenarians with lung cancer

(HealthDay)—Receiving treatment is associated with better survival for nonagenarians with non-small cell lung cancer (NSCLC), with the greatest survival benefit for stage I patients, according to a study published online ...

Oncology & Cancer

Lung cancer incidence rates generally declined from 2007 to 2016

(HealthDay)—The incidence rates of lung cancer declined in most age and sex groups from 2007 to 2016, with the smallest decrease seen among women living in nonmetropolitan counties, according to research published in the ...

Oncology & Cancer

Are we overestimating lifetime cancer risks?

The method employed in Australia to calculate the lifetime risks of cancer diagnosis and mortality overestimates these risks, especially for men, according to the authors of research published online today by the Medical ...

Oncology & Cancer

Discovery: New biomarker for cancer stem cells

In the world of cancer biology, not all biomarkers are created equal. These molecules that alert doctors that an abnormal process may be underway can appear as an array of aberrant proteins, such as hormones, enzymes or signaling ...

page 2 from 23